BPIA submits comments regarding Draft Guidance on Field Trial Requirements for Efficacy and Phytotoxicity Data.
Top News
Read More
BPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2023 in the Senate and the U.S. House of Representatives (H.R. 1472). BPIA thanks Senators Mike Braun (R-IN) and Alex Padilla (D-CA) as well as Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) for sponsoring the bill.
BPIA and other industry stakeholders suggested the PMRA consider reviewing and modernizing regulations for dual property products containing crop protection and crop health improvement properties to enable registration of these products under single label.